hec96719
Showing 1 - 3 of 3
Non-Alcoholic Steatohepatitis Trial in China (HEC96719, Placebo)
Recruiting
- Non-Alcoholic Steatohepatitis
- HEC96719
- Placebo
-
Beijing, Beijing, China
- +8 more
May 25, 2022
Nonalcoholic Steatohepatitis (NASH) Trial in Shanghai (HEC96719)
Completed
- Nonalcoholic Steatohepatitis (NASH)
- HEC96719
-
Shanghai, Shanghai, ChinaThe Shanghai xuhui district central hospital
May 6, 2021
Non-alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis Trial in Melbourne (HEC96719)
Completed
- Non-alcoholic Fatty Liver Disease
- Non-alcoholic Steatohepatitis
- HEC96719
-
Melbourne, Melbourne VIC 3004, AustraliaNucleus Network Pty Ltd
May 6, 2021